Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Apr 11;15(5):712–719.e4. doi: 10.1016/j.cgh.2016.03.045

Table 1.

Subject Demographics and IBS Subtypes

Fiber (n = 37) Placebo (n = 47) P value
Demographics
 Age, y 13.1 ± 0.4a 13.5 ± 0.4 .50
 Female 19 (51%)b 29 (62%) .38
Race .26
 White 26 (70%) 25 (53%)
 Black 4 (11%) 7 (15%)
 Asian 0 2 (4%)
 Hispanic 6 (16%) 13 (28%)
Insurance type .22
 PPO/HMO 33 (89%) 34 (73%)
 Medicaid/CHIP 4 (11%) 10 (21%)
 Other 0 2 (4%)
 None 0 1 (2%)
IBS subtype .32
 Constipation 18 23
 Unsubtyped 18 18
 Mixed 0 2
 Diarrhea 1 4

CHIP, children’s health insurance plan; HMO, health maintenance organization; PPO, preferred provider organization.

a

Means ± SEM.

b

Percentage.